Uncategorized
« Previous Entries Next Entries »Thursday’s Top Medical & Biotech Stocks
Friday, April 11th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
GENETIC TECH SPON [GENE] +18.21%
TRUBION PHARMACEUTIC [TRBN] +15.83%
XENACARE HOLDINGS [XCHO.OB] +15.38%
VION PHARMACEUTICALS [VION] +14.97%
NORTHFIELD LABS IN [NFLD] +13.86%
Diagnostic Substances
AVIGEN INC [AVGN] +14.58%
ISTA PHARMACTLS [ISTA] +9.41%
HUMAN GENOME SCI [HGSI] +8.33%
INFINITY […]
Aida Pharma Affiliate Developing New Antibiotic
Thursday, April 10th, 2008Submitted by BioHealth Investor Blog
by Richard Daverman, PhD
ChinaBio Today
Aida Pharmaceuticals, Inc. (OTCBB: AIDA) is working on a new wide-spectrum antibiotic that was discovered by its recently acquired affiliate, the Jiangsu Institute of Microbiology Co., Ltd (JSIM). Wetimicin, which belongs to a new generation of amino-glycoside antibiotics, is in Phase I trials. Aida believes the product […]
Wednesday’s Top Medical & Biotech Stocks
Thursday, April 10th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
PROTEO INC [PTEO.OB] +31.19%
CHAMPIONS BIOTECHNLG [CSBR.OB] +9.52%
IOMAI CORPORATION [IOMI] +9.43%
LPATH INC [LPTN.OB] +9.03%
GENAERA CORP [GENR] +8.21%
Diagnostic Substances
ISTA PHARMACTLS [ISTA] +13.48%
TORREYPINES THERAPEU [TPTX] +6.37%
REMOTEMDX INC [RMDX.OB] +3.40%
AVALON PHARMACEUTIC [AVRX] +1.85%
AVIGEN […]
Host of pricing models proposed for UK drugs
Wednesday, April 9th, 2008Submitted by THE HEALTH ECONOMICS BLOG
April 09, 2008
Financial Times
COMPANIES - UK
UK pharmaceuticals companies are introducing new drug pricing models as pressure mounts to offer better value for money.
The National Institute for Health and Clinical Excellence (Nice), the government’s medicines advisory body that studies clinical and cost effectiveness, has agreed three different experimental approaches to pricing […]
Drug Recycling: Not Much of a Solution
Wednesday, April 9th, 2008Submitted by BioHealth Investor Blog
by David E. Williams
Health Business Blog
The Associated Press reports that most US states have implemented “drug recycling” programs or are considering doing so. The basic idea is to accept donations of unused drugs and re-dispense them to people in need. It sounds like a good idea on the surface. After all, […]
Tuesday’s Top Medical & Biotech Stocks
Wednesday, April 9th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
ANTIGENICS INC [AGEN] +22.67%
ADVANCED LIFE SCIENC [ADLS] +16.68%
PLURISTEM THERAPEUTC [PSTI] +15.44%
REPLIGEN CP [RGEN] +14.10%
ARTES MEDICAL, INC. [ARTE] +11.11%
Diagnostic Substances
IMMUCELL CP [ICCC] +10.26%
ISTA PHARMACTLS [ISTA] +7.23%
ROSETTA GENOMICS LTD [ROSG] +4.82%
SCOLR […]
Nanogen Strengthens Active Partnering and Licensing Program
Wednesday, April 9th, 2008Submitted by BioHealth Investor Blog
by Doug Cress
Med Tech Sentinel
Nanogen and Thermo Fisher Scientific Partner to Provide Molecular Biology Products to the Research Market
As the biomedical industry works to gain a better understanding of the molecular basis of disease, the need for specific methods to detect genetic variation are becoming increasingly central to research.
San Diego, CA-based […]
Monday’s Top Medical & Biotech Stocks
Wednesday, April 9th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
PLURISTEM THERAPEUTC [PSTI] +107.90%
TRANSDEL PHARMACTL [TDLP.OB] +54.55%
METABASIS THERAPEUTI [MBRX] +21.29%
AETERNA ZENTARIS [AEZS] +17.14%
LIFECELL CP [LIFC] +16.94%
Diagnostic Substances
TORREYPINES THERAPEU [TPTX] +16.91%
MONOGRAM BIOSCIENCES [MGRM] +5.26%
ROSETTA GENOMICS LTD [ROSG] +4.85%
ISTA PHARMACTLS [ISTA] […]
No Recession in Healthcare
Monday, April 7th, 2008Submitted by BioHealth Investor Blog
by David E. Williams
Health Business Blog
The housing market’s in a tailspin, gas and food prices are crazy and the “R” word is in the air. Retailers are seeing a drop in business and more people are taking public transportation.
But you wouldn’t know about any sort of slowdown if you did what […]
No Recession in Healthcare
Monday, April 7th, 2008Submitted by BioHealth Investor Blog
by David E. Williams
Health Business Blog
The housing market’s in a tailspin, gas and food prices are crazy and the “R” word is in the air. Retailers are seeing a drop in business and more people are taking public transportation.
But you wouldn’t know about any sort of slowdown if you did what […]
Friday’s Top Medical & Biotech Stocks
Monday, April 7th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
XENACARE HOLDINGS [XCHO.OB] +28.71%
OPEXA THERAPEUTICS [OPXA] +27.83%
MEDICINOVA, INC. [MNOV] +11.11%
REPLIGEN CP [RGEN] +11.09%
SUNESIS PHARMACEUTIC [SNSS] +10.67%
Diagnostic Substances
ISTA PHARMACTLS [ISTA] +13.57%
INFINITY PHARMACEUTI [INFI] +9.49%
HUMAN GENOME SCI [HGSI] +4.41%
IMMUCOR INC [BLUD] […]
A Biotech Turnaround?
Friday, April 4th, 2008Submitted by BioHealth Investor Blog
by Michael Shulman
BiotechBlitz
Are biotech’s turning around? They are certainly beating the market and, frankly, worrying about FDA decisions is easier now than worrying about how much toxic waste is hidden on a bank’s balance sheet.
I have a good feel for the odds of whether Cell Genesys (CEGE) will get an approval […]
Thursday’s Top Medical & Biotech Stocks
Friday, April 4th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
IDM PHARMA INC [IDMI] +15.37%
ADVANCED LIFE SCIENC [ADLS] +14.69%
ANESIVA INC [ANSV] +14.33%
IOMAI CORPORATION [IOMI] +12.82%
CYTORI THERAPEUTICS [CYTX] +11.00%
Diagnostic Substances
INTERLEUKIN GENETICS [ILI] +14.29%
IMMUCELL CP [ICCC] +11.67%
TORREYPINES THERAPEU [TPTX] +7.41%
PRESSURE BIOSCIENC […]
Summer Institute in Pharmacoepidemiology and Outcomes in Rhode Island, USA
Thursday, April 3rd, 2008Submitted by THE HEALTH ECONOMICS BLOG
The University of Rhode Island College of Pharmacy will hold the second annual Summer Institute in Pharmacoepidemiology on June 9-11, 2008 at the Whispering Pines Conference Center of the Alton Jones Campus of the University of Rhode Island in West Greenwich, Rhode Island.
The Summer Institute in Pharmacoepidemiology was conceived to […]
Novare Surgical Removes Appendix via Vagina
Wednesday, April 2nd, 2008Submitted by BioHealth Investor Blog
by Doug Cress
Med Tech Sentinel
Sorry guys, we’re out of luck.
Novare Surgical Systems announced today the successful completion of an appendix removal performed using its RealHand HD instruments. Two surgeons from the UC San Diego Medical Center removed an inflamed appendix through a patient’s vagina, a first in the U.S.
Only one incision […]
Tuesday’s Top Medical & Biotech Stocks
Wednesday, April 2nd, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
CELL GENESYS INC [CEGE] +31.49%
IDENIX PHARMACEUT [IDIX] +20.32%
ARTES MEDICAL, INC. [ARTE] +19.23%
KOSAN BIOSCIENCES [KOSN] +19.11%
INTERMUNE INC [ITMN] +18.59%
Diagnostic Substances
IMMUCOR INC [BLUD] +10.59%
AVANT IMMUNOTHERAPEU [AVAND] +9.18%
PRESSURE BIOSCIENC [PBIO] +8.68%
MONOGRAM BIOSCIENCES […]
Monday’s Top Medical & Biotech Stocks
Wednesday, April 2nd, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
TRANSDEL PHARMACTL [TDLP.OB] +17.45%
BIOCRYST PHARM INC [BCRX] +13.55%
GENAERA CORP [GENR] +12.67%
GENETIC TECH SPON [GENE] +10.89%
ACHILLION PHARMACEUT [ACHN] +9.38%
Diagnostic Substances
INTERLEUKIN GENETICS [ILI] +7.41%
ICAGEN, INC. [ICGN] +7.28%
AVIGEN INC [AVGN] +3.33%
AMAG PHARMACEUTICALS […]
UK turns to value based pricing of pharmaceuticals
Monday, March 31st, 2008Submitted by THE HEALTH ECONOMICS BLOG
PINK-SHEET, March 31, 2008, Page 22 copyright 2008, F-D-C Reports, Inc.
The British Department of Health has notified drug companies that it is ending the current Pharmaceutical Pricing Regulation Scheme as of Aug. 31 and will examine other approaches, such as “value-based” drug pricing.
The current pricing scheme, which governs drugs sold […]
Cephalon: New Player in Chronic Lymphocytic Leukemia
Monday, March 31st, 2008Submitted by BioHealth Investor Blog
by Hisham S. Ayoub, DMD
BioHealth Investor
For the first time in seven years a new therapy for Chronic Lymphocytic Leukemia (CLL) has been cleared in the U.S. by the FDA. Biotech firm Cephalon’s (CEPH) TREANDA (bendamustine hydrochloride) was given final approval by the FDA on March 20, only six months after the […]
The FDA and Overseas Drug Approvals
Monday, March 31st, 2008Submitted by BioHealth Investor Blog
by Mark Senak
Eye On FDA
Where is the Most Promising Pipeline?
For a while now, I’ve been thinking about the growing number of drugs that are being approved overseas and going on the market overseas, but are not getting approved or are getting approvable letters in the U.S. It is a list that […]
Fund Mangers bullish on pharma stocks in the long run
Friday, March 28th, 2008Submitted by THE HEALTH ECONOMICS BLOG
FT.com site : View of the day: Pharmaceuticals.
March 27, 2008Financial Times (FT.Com)
The market’s attitude towards the pharmaceutical industry has changed dramatically over the last decade. The rise of generics, perceived pipeline issues and pricing have all led to a major de-rating of these stocks. This presents a huge opportunity,” says […]
NICE recommends Sanofi Aventis’ Obesity drug
Friday, March 28th, 2008Submitted by THE HEALTH ECONOMICS BLOG
by Michael McKenna
“The UK’s National Institute for Health and Clinical Excellence on Wednesday issued final appraisal determination recommending that sanofi-aventis’ obesity drug, Acomplia (rimonabant), be made available on the NHS for certain patients. Sanofi-aventis noted that a final decision from NICE is expected in “due course.”
The agency recommended that the […]
Friday’s Top Medical & Biotech Stocks
Friday, March 28th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
PROTEO INC [PTEO.OB] +93.07%
BIOSANTE PHARMA INC [BPAX] +19.39%
TRANSDEL PHARMACTL [TDLP.OB] +19.20%
HESKA CORPORATION [HSKA] +18.52%
HEMOBIOTECH INC [HMBT.OB] +18.18%
Diagnostic Substances
REMOTEMDX INC [RMDX.OB] +13.42%
RESPONSE GENETICS, I [RGDX] +8.11%
INFINITY PHARMACEUTI [INFI] +6.82%
SYNTA PHARMACEUTICAL […]
Drugs: Penny Wise, But a Pound Foolish
Friday, March 28th, 2008Submitted by BioHealth Investor Blog
by Michael Shulman
BiotechBlitz
I typically write about stocks of interest to investors, but today I am just hacked off. Bear with me and pardon the pun.
Not all drugs and biotech companies are created equal — and the belief that a drug may cost too much because of its price, is representative of […]
Thursday’s Top Medical & Biotech Stocks
Friday, March 28th, 2008Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
IMMUNOSYN CORPORATIN [IMYN.OB] +19.90%
BIOSANTE PHARMA INC [BPAX] +19.88%
TITAN PHARMA INC [TTP] +14.17%
REXAHN PHARMACEUTICL [RXHN.OB] +13.64%
ANESIVA INC [ANSV] +10.00%
Diagnostic Substances
IMMUCELL CP [ICCC] +25.02%
TORREYPINES THERAPEU [TPTX] +18.32%
REMOTEMDX INC [RMDX.OB] +10.37%
AVANT IMMUNOTHERAPEU […]
